{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:56:02Z","timestamp":1793854562432,"version":"4.6.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jaut.2022.102951","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T03:03:21Z","timestamp":1669950201000},"page":"102951","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1342-9135","authenticated-orcid":false,"given":"Charlotta","family":"Preger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Notarnicola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Hellstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edvard","family":"Wigren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e1tia","family":"Fernandes-Cerqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Kvarnstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Wahren-Herlenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Idborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid E.","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Gr\u00e4slund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Johan","family":"Jakobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jaut.2022.102951_bib1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00408-016-9896-x","article-title":"Assessment of mortality in autoimmune myositis with and without associated interstitial lung disease","volume":"194","author":"Johnson","year":"2016","journal-title":"Lung"},{"issue":"1","key":"10.1016\/j.jaut.2022.102951_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/annrheumdis-2017-211402","article-title":"Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study","volume":"77","author":"Dobloug","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.jaut.2022.102951_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/13497413.2018.1481571","article-title":"Myositis an evolving spectrum of disease","volume":"41","author":"Barsotti","year":"2018","journal-title":"Immunol Med"},{"issue":"6","key":"10.1016\/j.jaut.2022.102951_bib4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","article-title":"A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups","volume":"70","author":"Love","year":"1991","journal-title":"Medicine (Baltim.)"},{"issue":"3","key":"10.1016\/j.jaut.2022.102951_bib5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/emmm.201100626","article-title":"Aminoacyl-tRNA synthetases in medicine and disease","volume":"5","author":"Yao","year":"2013","journal-title":"EMBO Mol. Med."},{"issue":"8","key":"10.1016\/j.jaut.2022.102951_bib6","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41573-019-0026-3","article-title":"Aminoacyl-tRNA synthetases as therapeutic targets","volume":"18","author":"Kwon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.jaut.2022.102951_bib7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.rdc.2019.07.006","article-title":"Idiopathic inflammatory myopathies","volume":"45","author":"Vencovsky","year":"2019","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"7","key":"10.1016\/j.jaut.2022.102951_bib8","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/art.24631","article-title":"Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease","volume":"60","author":"Richards","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.jaut.2022.102951_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060442","article-title":"Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome","volume":"8","author":"Hamaguchi","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jaut.2022.102951_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/joim.12451","article-title":"Myositis-specific autoantibodies: an important tool to support diagnosis of myositis","volume":"280","author":"Betteridge","year":"2016","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jaut.2022.102951_bib11","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaut.2019.04.001","article-title":"Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients","volume":"101","author":"Betteridge","year":"2019","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.jaut.2022.102951_bib12","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s10067-020-05273-3","article-title":"Myositis-specific autoantibodies in adults with idiopathic inflammatory myopathy: correlations with diagnosis and disease activity","volume":"40","author":"Zhao","year":"2021","journal-title":"Clin. Rheumatol."},{"issue":"5","key":"10.1016\/j.jaut.2022.102951_bib13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/CPM.0000000000000171","article-title":"The diagnosis and treatment of antisynthetase syndrome","volume":"23","author":"Witt","year":"2016","journal-title":"Clin. Pulm. Med."},{"issue":"6","key":"10.1016\/j.jaut.2022.102951_bib14","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1084\/jem.20020186","article-title":"Histidyl-tRNA synthetase and asparaginyl-tRNA synthetase, autoantigens in myositis, activate chemokine receptors on T lymphocytes and immature dendritic cells","volume":"196","author":"Howard","year":"2002","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.jaut.2022.102951_bib15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0165-2478(95)02469-7","article-title":"Tryptophanyl-tRNA synthetase as a human autoantigen","volume":"48","author":"Paley","year":"1995","journal-title":"Immunol. Lett."},{"issue":"4","key":"10.1016\/j.jaut.2022.102951_bib16","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s13311-018-00676-2","article-title":"Autoimmune myopathies: updates on evaluation and treatment","volume":"15","author":"McGrath","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"7","key":"10.1016\/j.jaut.2022.102951_bib17","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.autrev.2019.05.002","article-title":"Anti-OJ autoantibodies: rare or underdetected?","volume":"18","author":"Vulsteke","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2022.102951_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102680","article-title":"Immune recognition of lysyl-tRNA synthetase and isoleucyl-tRNA synthetase by anti-OJ antibody-positive sera","volume":"122","author":"Muro","year":"2021","journal-title":"J. Autoimmun."},{"issue":"14","key":"10.1016\/j.jaut.2022.102951_bib19","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1074\/jbc.REV118.002958","article-title":"Evolution of the multi-tRNA synthetase complex and its role in cancer","volume":"294","author":"Hyeon","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2022.102951_bib20","first-page":"147","article-title":"The Swedish Rheumatology Quality Register: optimisation of rheumatic disease assessments using register-enriched data","volume":"32","author":"Eriksson","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.jaut.2022.102951_bib21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/annrheumdis-2017-211868","article-title":"The EuroMyositis registry: an international collaborative tool to facilitate myositis research","volume":"77","author":"Lilleker","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.jaut.2022.102951_bib22","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.40320","article-title":"European League against rheumatism\/American College of rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"69","author":"Lundberg","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.jaut.2022.102951_bib23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"Immune-mediated necrotizing myopathies working G. 224th ENMC international workshop:: clinico-sero-pathological classification of immune-mediated necrotizing myopathies zandvoort, The Netherlands, 14-16 october","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul. Disord."},{"issue":"6","key":"10.1016\/j.jaut.2022.102951_bib24","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?","volume":"138","author":"Connors","year":"2010","journal-title":"Chest"},{"issue":"Suppl 11","key":"10.1016\/j.jaut.2022.102951_bib25","first-page":"S118","volume":"63","author":"Rider","year":"2011","journal-title":"Arthritis Care Res."},{"issue":"6","key":"10.1016\/j.jaut.2022.102951_bib26","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.jaut.2022.102951_bib27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/tan.12093","article-title":"Common and well-documented HLA alleles: 2012 update to the CWD catalogue","volume":"81","author":"Mack","year":"2013","journal-title":"Tissue Antigens"},{"issue":"11","key":"10.1016\/j.jaut.2022.102951_bib28","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.jaut.2022.102951_bib29","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.jaut.2022.102951_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"American College of rheumatology\/European League against rheumatism classification criteria for primary sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"10.1016\/j.jaut.2022.102951_bib31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.jaut.2022.102951_bib32","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.jaut.2022.102951_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/biot.200800183","article-title":"High-throughput protein production--lessons from scaling up from 10 to 288 recombinant proteins per week","volume":"4","author":"Tegel","year":"2009","journal-title":"Biotechnol. J."},{"issue":"17","key":"10.1016\/j.jaut.2022.102951_bib34","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1002\/pmic.200500072","article-title":"Towards a human proteome atlas: high-throughput generation of mono-specific antibodies for tissue profiling","volume":"5","author":"Nilsson","year":"2005","journal-title":"Proteomics"},{"issue":"41","key":"10.1016\/j.jaut.2022.102951_bib35","doi-asserted-by":"crossref","first-page":"13981","DOI":"10.1074\/jbc.RA120.012893","article-title":"Generation and validation of recombinant antibodies to study human aminoacyl-tRNA synthetases","volume":"295","author":"Preger","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2022.102951_bib36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-1-4614-7209-4_8","article-title":"Highly multiplexed antibody suspension bead arrays for plasma protein profiling","volume":"1023","author":"Drobin","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jaut.2022.102951_bib37","series-title":"Cerebrospinal Fluid (CSF) Proteomics: Methods and Protocols","first-page":"303","article-title":"Array-based profiling of proteins and autoantibody repertoires in CSF","author":"Pin","year":"2019"},{"issue":"1","key":"10.1016\/j.jaut.2022.102951_bib38","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-022-02745-6","article-title":"Longitudinal assessment of reactivity and affinity profile of anti-Jo1 autoantibodies to distinct HisRS domains and a splice variant in a cohort of patients with myositis and anti-synthetase syndrome","volume":"24","author":"Notarnicola","year":"2022","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.jaut.2022.102951_bib39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00428-017-2269-x","article-title":"Anti-aminoacyl-tRNA synthetase-related myositis and dermatomyositis: clues for differential diagnosis on muscle biopsy","volume":"472","author":"Cerbelli","year":"2018","journal-title":"Virchows Arch."},{"issue":"Pt 9","key":"10.1016\/j.jaut.2022.102951_bib40","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1093\/brain\/awv192","article-title":"Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis","volume":"138","author":"Mescam-Mancini","year":"2015","journal-title":"Brain"},{"issue":"Pt 9","key":"10.1016\/j.jaut.2022.102951_bib41","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1093\/brain\/aww125","article-title":"Perifascicular necrosis in anti-synthetase syndrome beyond anti","volume":"139","author":"Uruha","year":"2016","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.jaut.2022.102951_bib42","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrrheum.2018.56","article-title":"Autoantibodies in myositis","volume":"14","author":"McHugh","year":"2018","journal-title":"Nat. Rev. Rheumatol."},{"issue":"8","key":"10.1016\/j.jaut.2022.102951_bib43","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1093\/rheumatology\/keaa021","article-title":"The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificity","volume":"59","author":"Tansley","year":"2020","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.jaut.2022.102951_bib44","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41584-020-00522-w","article-title":"Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases","volume":"16","author":"Bossuyt","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.jaut.2022.102951_bib45","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.febslet.2009.11.064","article-title":"Functional expansion of human tRNA synthetases achieved by structural inventions","volume":"584","author":"Guo","year":"2010","journal-title":"FEBS Lett."},{"issue":"14","key":"10.1016\/j.jaut.2022.102951_bib46","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1074\/jbc.REV118.002956","article-title":"Progress and challenges in aminoacyl-tRNA synthetase-based therapeutics","volume":"294","author":"Francklyn","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.jaut.2022.102951_bib47","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1172\/JCI116493","article-title":"Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase","volume":"91","author":"Targoff","year":"1993","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.jaut.2022.102951_bib48","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.autrev.2018.10.004","article-title":"Autoantibodies in idiopathic inflammatory myopathies: clinical associations and laboratory evaluation by mono- and multispecific immunoassays","volume":"18","author":"Damoiseaux","year":"2019","journal-title":"Autoimmun. Rev."},{"issue":"7","key":"10.1016\/j.jaut.2022.102951_bib49","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/art.34380","article-title":"Prevalence and sociodemographic correlates of antinuclear antibodies in the United States","volume":"64","author":"Satoh","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.jaut.2022.102951_bib50","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/rheumatology\/kem045","article-title":"Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia","volume":"46","author":"Betteridge","year":"2007","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.jaut.2022.102951_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08916934.2019.1581774","article-title":"Individual and stable autoantibody repertoires in healthy individuals","volume":"52","author":"Neiman","year":"2019","journal-title":"Autoimmunity"},{"issue":"11","key":"10.1016\/j.jaut.2022.102951_bib52","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.24827","article-title":"Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis","volume":"61","author":"Aggarwal","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.jaut.2022.102951_bib53","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1002\/art.23763","article-title":"Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease","volume":"58","author":"Ioan-Facsinay","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2022.102951_bib54","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fmed.2018.00339","article-title":"The clinical value of autoantibodies in rheumatoid arthritis","volume":"5","author":"Bugatti","year":"2018","journal-title":"Front. Med."},{"issue":"9","key":"10.1016\/j.jaut.2022.102951_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092944","article-title":"Prevalence of novel myositis autoantibodies in a large cohort of patients with interstitial lung disease","volume":"9","author":"Moll","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jaut.2022.102951_bib56","doi-asserted-by":"crossref","DOI":"10.1177\/2040622320968417","article-title":"Interstitial lung disease is a major characteristic of anti-KS associated ant-synthetase syndrome","volume":"11","author":"Ge","year":"2020","journal-title":"Ther Adv Chronic Dis"},{"issue":"9","key":"10.1016\/j.jaut.2022.102951_bib57","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/art.1780390910","article-title":"Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis","volume":"39","author":"Arnett","year":"1996","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.jaut.2022.102951_bib58","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/art.1780330826","article-title":"HLA-D Region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis","volume":"33","author":"Goldstein","year":"1990","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.jaut.2022.102951_bib59","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.md.0000189818.63141.8c","article-title":"Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians","volume":"84","author":"O'Hanlon","year":"2005","journal-title":"Medicine (Baltim.)"},{"issue":"6","key":"10.1016\/j.jaut.2022.102951_bib60","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/annrheumdis-2011-200182","article-title":"Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study","volume":"71","author":"Chinoy","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2022.102951_bib61","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/bs.enz.2020.06.009","article-title":"Human diseases linked to cytoplasmic aminoacyl-tRNA synthetases","author":"Jiang","year":"2020","journal-title":"Biology of Aminoacyl-tRNA Synthetases. The Enzymes"},{"issue":"1","key":"10.1016\/j.jaut.2022.102951_bib62","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0049-0172(96)80026-6","article-title":"Interstitial lung disease with autoantibodies against aminoacyl-tRNA synthetases in the absence of clinically apparent myositis","volume":"26","author":"Friedman","year":"1996","journal-title":"Semin. Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.jaut.2022.102951_bib63","doi-asserted-by":"crossref","first-page":"309","DOI":"10.55563\/clinexprheumatol\/8xj0b9","article-title":"Defining anti-synthetase syndrome: a systematic literature review","volume":"40","author":"Zanframundo","year":"2022","journal-title":"Clin. Exp. Rheumatol."},{"issue":"6","key":"10.1016\/j.jaut.2022.102951_bib64","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/rheumatology\/kev444","article-title":"Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab","volume":"55","author":"Aggarwal","year":"2016","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.jaut.2022.102951_bib65","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/rheumatology\/ker408","article-title":"Disappearance of anti-MDA-5 autoantibodies in clinically amyopathic DM\/interstitial lung disease during disease remission","volume":"51","author":"Muro","year":"2012","journal-title":"Rheumatology"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841122001597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841122001597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:30:36Z","timestamp":1760257836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841122001597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":65,"alternative-id":["S0896841122001597"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2022.102951","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.06.13.495951","asserted-by":"object"}]},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantigenic properties of the aminoacyl tRNA synthetase family in idiopathic inflammatory myopathies","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2022.102951","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102951"}}